Joel Michael Maryles, Director at Chemomab Therapeutics Ltd. (CMMB), bought 433 shares at $2.89 ($1K) on 2022-05-24, disclosed to the SEC on 2022-05-25.
Open-market purchase of $1k CMMB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.76 | 33 | $91 | 7.3% |
| 2 | $2.89 | 400 | $1K | 92.7% |
| Total | $2.88 avg | 433 | $1K | 100% |